Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (HCAT) delivers data analytics and technology solutions that empower healthcare organizations to improve clinical outcomes. This page serves as a comprehensive resource for investors and industry professionals tracking the company’s strategic developments.
Key updates include earnings reports, product launches, leadership changes, and partnership announcements. Users will find verified press releases and curated news articles covering HCAT’s technology innovations, client expansions, and financial performance.
Regular updates feature developments in healthcare data warehousing, cloud analytics platforms, and professional service offerings. Content highlights operational milestones, regulatory compliance achievements, and market expansion efforts within the healthcare IT sector.
Bookmark this page to monitor Health Catalyst’s progress in enabling data-driven care improvements through its adaptive data architecture and analytics expertise. Check back for objective reporting on HCAT’s role in advancing healthcare interoperability and operational efficiency.
Health Catalyst (Nasdaq: HCAT) is set to release its fourth quarter and full year 2022 operating results on February 28, 2023, after market close. A conference call will follow at 5 p.m. E.T. to discuss the results. Interested parties can dial in using (800) 343-5172 for U.S. participants or (785) 424-1699 internationally, referencing the conference ID “HCAT Q422.” A live audio webcast will also be available, with a replay accessible for approximately 90 days afterward. Health Catalyst offers data and analytics technology to healthcare organizations, aiming for significant improvements through data-informed decisions.
Health Catalyst (Nasdaq: HCAT) announced that COO Paul Horstmeier will serve as Mission President for the Church of Jesus Christ of Latter-Day Saints in Puerto Rico, effective late June 2023. He will transition to Senior Advisor on March 31, 2023, and assist in the transition of his responsibilities. CEO Dan Burton praised Horstmeier's significant contributions over the past 11.5 years. This marks the second time a senior leader at Health Catalyst has taken on such a role, following Co-Founder Steve Barlow's service in Ecuador from 2017 to 2020.
Health Catalyst, a leader in healthcare data and analytics, announced participation in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco. CEO Dan Burton, CFO Bryan Hunt, and SVP Adam Brown will present on January 10, 2023, at 3:45 PM PT. A replay of the presentation will be available online. Health Catalyst utilizes a cloud-based platform powered by data from over 100 million patient records, enabling healthcare organizations to make data-driven decisions and enhance clinical, financial, and operational outcomes.
On December 5, 2022, Health Catalyst (Nasdaq: HCAT) announced a significant, multi-year agreement with Carle Health, enhancing their existing partnership. This five-year contract aims to improve Carle Health's analytics capabilities and includes an all-access technology subscription along with tech-enabled managed services. Starting January 2023, Carle Health's Clinical and Business Intelligence team will join Health Catalyst, allowing for professional growth and continued innovation in analytics support. This partnership reaffirms Health Catalyst's strong market position and is expected to positively impact patient outcomes.
Health Catalyst, a provider of data and analytics technology for healthcare, reported third-quarter 2022 results showing an 11% revenue increase year-over-year to $68.35 million. The company exceeded guidance for revenue and Adjusted EBITDA, with technology revenue rising 15% to $44 million. Adjusted EBITDA improved by 21%, showcasing operational efficiency. Health Catalyst also raised its full year 2022 revenue and Adjusted EBITDA guidance, expecting a dollar-based retention level between 97% and 101%. These results reflect strong client expansion and effective cost-reduction strategies.
Health Catalyst (Nasdaq: HCAT) announces that its KPI Ninja solution has received NCQA Certification for HEDIS® Measures for the third consecutive year. This certification validates KPI Ninja's measure logic for accurate patient data results, supporting Health Information Exchanges (HIEs) in transitioning to value-based care. The achievement demonstrates KPI Ninja's ongoing commitment to quality measures, essential for healthcare organizations aiming for enhanced population health outcomes. The certification reinforces Health Catalyst's reputation as a leading provider of data and analytics technology in healthcare.
Health Catalyst, Inc. (Nasdaq: HCAT) will release its Q3 2022 operating results on November 8, 2022, after market close. Following the release, a conference call for analysis will occur at 5 p.m. E.T. Participants can join by dialing (800) 225-9448 for U.S. calls or (203) 518-9708 internationally, using conference ID “HCAT Q322.” The call will also be available via a live audio webcast. Health Catalyst focuses on providing data and analytics services to healthcare organizations, leveraging a cloud-based platform analyzing over 100 million patient records to drive healthcare improvements.
On September 14, 2022, Health Catalyst (HCAT) announced the winners of its fourth annual Catalyst Awards during the Healthcare Analytics Summit 2022. The awards honor healthcare organizations for their outstanding use of data and analytics. The University of Kansas Health System received the Flywheel Award for its significant healthcare improvements, including $4.7 million in cost savings and a 39% reduction in 30-day readmissions. Other winners included INTEGRIS Health, WakeMed Health and Hospitals, Indiana University Health, and UnityPoint Health, each recognized for their innovative practices in analytics and patient care.
On September 7, 2022, Health Catalyst (Nasdaq: HCAT) announced new leadership appointments to strengthen its strategic focus areas. Kevin Freeman has been named Chief Growth Officer, while Tarah Neujahr Bryan becomes Chief Marketing Officer. Both will prioritize expanding client relationships. Dave Ross is appointed Chief Technology Officer to enhance data and analytics infrastructure. Effective September 30, 2022, Patrick Nelli transitions to Senior Advisor, and Bryan Hinton completes his tenure. CEO Dan Burton highlighted these changes as pivotal for the company's mission of data-informed healthcare improvements.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
